Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Efficacy and Safety of Baroreflex Activation Therapy in Patients With Refractory Hypertension and Those With Highly Variable Blood Pressure Due to Peripheral Baroreflex Failure

NCT03730519 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT03730519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03730519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Efficacy and Safety of Baroreflex Activation Therapy in Patients With Refractory Hypertension and Those With Highly Variable Blood Pressure Due to Peripheral Baroreflex Failure
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Terminated
Start date
November 1, 2018
Completion date
November 1, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

baroreflex failure syndrome, hypertension, resistant to conventional therapy